Nitta Gelatin Inc. (4977.T) stock price, financials & research

Regular session · JST · Market data may be delayed.

Company profile

Established in Osaka, Japan, in 1918, Nitta Gelatin Inc. is a leading manufacturer and supplier primarily focused on gelatin and collagen products. The company's operations encompass the production and distribution of edible, pharmaceutical, and photographic gelatin, predominantly within the Japanese market. Utilizing raw materials like animal bones and skin, as well as fish scales and skin, they also develop a varied range of collagen-derived products. This includes industrial-grade gelatin for both food and pharmaceutical industries, alongside collagen peptides, which are known for their bioactive and bioregulatory characteristics, produced using proprietary proteolytic technology. Additionally, Nitta Gelatin provides other food ingredients and stabilizers vital for confectionery, desserts, delicatessen items, and chilled foods. They further extend their expertise to the medical field, supplying specialized collagen and medical gelatin to device manufacturers and research institutions for use as biomaterials in applications such as artificial skin and bone.

Industry: Chemicals - Specialty
Sector: Basic Materials
Headquarters: JP
CEO: Hidenori Takemiya
Listed since: Dec 20, 2011
Employees: 851

Market position

Day range

Current ¥1,213

¥1,197¥1,214

52-week range

Current ¥1,213

¥964¥1,487

Open: ¥1,204
Previous close: ¥1,202
Volume: 31.6K; 0.79× average
Average volume: 39.97K; Average daily volume
Market cap: 22.09B JPY
Beta: 0.39; Market reference 1
50-day average: ¥1,292.54; -6.15% below average
200-day average: ¥1,251.53; -3.08% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 21.56B JPY
P/E (TTM): 6.59×
P/B (TTM): 0.88×
P/S (TTM): 0.57×
EV / EBITDA: 3.42×
Earnings yield: 14.93%
Free cash flow yield: 20.62%
Dividend yield: 2.47%

Profitability & efficiency

Gross margin: 28.37%
Operating margin: 11.84%
Net margin: 8.63%
Return on equity: 13.53%
Return on assets: 7.66%
Return on invested capital: 11.06%

Financial health

Debt / equity: 0.2×
Current ratio: 3.23×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

38.05B JPY-1.80%

Operating income

4.66B JPY+18.65%

Net income

3.28B JPY+3.86%

Metric (JPY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	38.05B JPY	38.75B JPY	40.42B JPY	39.19B JPY	31.78B JPY
Cost of goods sold	27.07B JPY	28.79B JPY	32.13B JPY	30.29B JPY	24.78B JPY
Gross profit	10.98B JPY	9.96B JPY	8.29B JPY	8.9B JPY	7B JPY
Research and development	—	—	1.33B JPY	1.08B JPY	934M JPY
Selling, general, and administrative	6.32B JPY	6.03B JPY	5.55B JPY	5.85B JPY	4.76B JPY
Operating expenses	6.32B JPY	6.03B JPY	6.45B JPY	6.64B JPY	5.44B JPY
Interest income	153M JPY	132M JPY	48M JPY	7M JPY	2M JPY
Interest expense	74M JPY	104M JPY	190M JPY	171M JPY	97M JPY
Depreciation and amortization	1.41B JPY	1.27B JPY	1.73B JPY	1.63B JPY	1.42B JPY
Operating income	4.66B JPY	3.93B JPY	1.84B JPY	2.26B JPY	1.56B JPY
Net income	3.28B JPY	3.16B JPY	−1.85B JPY	1.56B JPY	726M JPY